This study also revealed new immune suppressive miR-200c targets that may dampen anti-tumor immunity in mTNBC, including tryptophan-2,3 dioxygenase (TDO2), chitinase-3 like-1 (CHI3L1) and heme oygenase-1 (HO-1). The gene discussed is CHI3L1; the disease is neoplasm.